Recalls and alerts more than 4 years old are automatically archived. While this information can still be accessed in the database, it has not been altered or updated since it was archived. Web pages that are archived on the Web are not subject to the Government of Canada Web Standards. As per the Communications Policy of the Government of Canada, you can request alternate formats by contacting us.
Recall of Cannabis for Medical Purposes - Aphria
- Starting date:
- March 8, 2017
- Type of communication:
- Drug Recall
- Hazard classification:
- Type III
- Source of recall:
- Health Canada
- Labelling and Packaging
- General Public
- Identification number:
On March 8, 2017, Aphria, a licensed producer of cannabis for medical purposes located in Ontario, began a voluntary recall of one lot of dried marijuana under a Type III recall. The affected lot number can be found below.
On March 8, 2017, Aphria initiated a voluntary Type III recall for one lot of product due to the mislabelling of the delta-9-tetrahydrocannabidiol (THC) content of the products. The THC content identified on the label was higher than the concentration present in the products. The products were mislabelled as containing 22.3% THC instead of 21.1% THC.
A Type III recall refers to a situation in which the use of, or exposure to a product, is not likely to cause any adverse health consequences.
To date, Health Canada has not received any adverse reaction reports for products sold by Aphria. However, Health Canada recommends that any individual affected by the recall immediately stop using the recalled product and to contact Aphria at the following number 1-844-427-4742.
DIN, NPN, DIN-HIMNot Applicable
Lot or serial number
The following lots are classified under the Type III recall initiated on March 8, 2017.
- Recalling Firm
- Marketing Authorization Holder
- Not Applicable
- Date modified: